Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
36627 POSTS 0 COMMENTS
Diet-induced weight loss is associated with a decrease in total hip

Review: Diet-Linked Weight Loss Tied to Drop in Hip BMD

0
No significant effect of diet-induced weight loss on lumbar spine or whole body bone mineral density
Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections

Ocular Bacteria Differ for Contact Lens Wearers

0
Finding may explain why lens wearers are more prone to infection
Targeted radiation in the treatment of brain metastases leads to less cognitive damage than radiation for the entire brain

ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits

0
Second study suggests new immunotherapy may benefit patients with glioblastoma
The first genetic marker to predict response to pembrolizumab (Keytruda) has been identified by researchers

ASCO: MMR Deficiency Predicts Pembrolizumab Response

0
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
For U.S. veterans with posttraumatic stress disorder

Sleep Apnea Risk Found to Rise With PTSD Severity in Veterans

0
Researcher suggests OSA screening for vets presenting for PTSD treatment
Two new targeted treatments have shown promise in slowing the progression of recurring chronic-lymphocytic leukemia and slow-growing non-Hodgkin's lymphoma

ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma

0
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Smokers and patients exposed to secondhand smoke may require more anesthesia and opioids during surgery than nonsmokers

Smoke Exposure May Create Need for More Anesthesia

0
Effect seems to extend to patients exposed to secondhand smoke, as well as smokers
Not all melanoma patients need surgery to remove lymph nodes surrounding their tumor

ASCO: Lymph Node Sx Doesn’t Benefit All Melanoma Patients

0
Second study supports new immunotherapy for enhanced survival in advanced melanoma
Adding palbociclib (Ibrance) to standard hormone therapy may benefit patients with advanced hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer over hormone therapy alone

ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer

0
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
Thousands of breast cancer patients in the United States might be spared a second surgery if more tissue was removed during initial breast-conserving

ASCO: Greater Breast Tissue Removal Reduces Further Surgery

0
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer